Triptan Therapy

Triptan Therapy is a pharmacological treatment approach within headache management that specifically involves the use of serotonin (5-HT1B/1D) receptor agonists to alleviate acute migraine attacks by promoting vasoconstriction and inhibiting neuropeptide release in cranial blood vessels.

404

Publications

19.7K

Citations

1.4K

Authors

623

Institutions

Publications per year

2017–2026

69

Variants

Triptan Treatment

Authors

1.4K

  1. RB
    Richard B. Lipton

    Albert Einstein College of Medicine, United States

    22 publications · 1.2K citations

    20

    h-index

  2. PJ
    Peter J. Goadsby

    King's College London, United Kingdom

    21 publications · 2.9K citations

    19

    h-index

  3. DW
    David W. Dodick

    Mayo Clinic in Arizona, United States

    16 publications · 1.6K citations

    15

    h-index

  4. SJ
    Stewart J. Tepper

    Dartmouth College, United States

    14 publications · 695 citations

    13

    h-index

  5. RC
    Roger Cady

    Headache Care Center, United States

    15 publications · 537 citations

    12

    h-index

1–5 of 1.4K

Venues

  1. Headache The Journal of Head and Face Pain

    102 publications · 4.7K citations

    43

    h-index

  2. Cephalalgia

    62 publications · 2.9K citations

    33

    h-index

  3. The Journal of Headache and Pain

    28 publications · 953 citations

    21

    h-index

  4. PubMed

    Repository · 23 publications · 901 citations

    17

    h-index

  5. Neurology

    13 publications · 1.8K citations

    12

    h-index

1–5